Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · IEX Real-Time Price · USD

1.195

+0.075 (6.70%)

At close: Jul 2, 2024, 4:00 PM

1.218

+0.023 (1.92%)

After-hours: Jul 2, 2024, 7:28 PM EDT

Gain Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-22.27	-17.59	-13.89	-3.58	-2.19	Upgrade
Depreciation & Amortization	0.08	0.06	0.02	0.01	0	Upgrade
Share-Based Compensation	3.26	1.53	0.84	0.08	0	Upgrade
Other Operating Activities	0.06	1.31	0.67	0.25	0.32	Upgrade
Operating Cash Flow	-18.87	-14.69	-12.37	-3.24	-1.87	Upgrade
Capital Expenditures	-0.02	-0.12	-0.09	-0.02	-0.01	Upgrade
Change in Investments	10.24	-14.66	0	0	0	Upgrade
Investing Cash Flow	10.22	-14.77	-0.09	-0.02	-0.01	Upgrade
Share Issuance / Repurchase	12.73	0	42.64	0	0	Upgrade
Debt Issued / Paid	-0.09	-0.08	-0.02	0.74	0	Upgrade
Other Financing Activities	-	-	-0.85	9.75	1.75	Upgrade
Financing Cash Flow	12.64	-0.08	41.77	10.49	1.75	Upgrade
Exchange Rate Effect	0.49	-0.02	0.1	-0.04	0.03	Upgrade
Net Cash Flow	4.49	-29.57	29.41	7.19	-0.1	Upgrade
Free Cash Flow	-18.88	-14.81	-12.46	-3.26	-1.88	Upgrade
Free Cash Flow Margin	-34217.53%	-10571.20%	-7551.72%	-11291.38%	-4557.35%	Upgrade
Free Cash Flow Per Share	-1.45	-1.25	-1.23	-1.22	-0.84	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).